Log on / register
Feedback | Support | My details
Open AccessHighly AccessResearch article

Large-scale RNAi screens identify novel genes that interact with the C. elegans retinoblastoma pathway as well as splicing-related components with synMuv B activity

Julian Ceron1,4 email, Jean-François Rual2 email, Abha Chandra1 email, Denis Dupuy2 email, Marc Vidal2 email and Sander van den Heuvel1,3 email

1Massachusetts General Hospital Cancer Center and Harvard Medical School, Building 149, 13th Street, Charlestown, 02129 MA, USA

2Center for Cancer Systems Biology (CCSB) and Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Genetics, Harvard Medical School, 44 Binney Street, Boston, 02115 MA, USA

3Department of Developmental Biology, Utrecht University, Kruytbuilding, Padualaan 8, 3584 CH Utrecht, The Netherlands

4Present address : Molecular Oncology and Aging Research, Centre d'Investigacions en Bioquímica I Biología Molecular (CIBBIM), Hospital Universitari Vall d'Hebron 119-129, Barcelona 08035, Spain

author email corresponding author email

BMC Developmental Biology 2007, 7:30doi:10.1186/1471-213X-7-30

Published: 6 April 2007

Abstract

Background

The retinoblastoma tumor suppressor (Rb) acts in a conserved pathway that is deregulated in most human cancers. Inactivation of the single Rb-related gene in Caenorhabditis elegans, lin-35, has only limited effects on viability and fertility, yet causes changes in cell-fate and cell-cycle regulation when combined with inactivation of specific other genes. For instance, lin-35 Rb is a synthetic multivulva (synMuv) class B gene, which causes a multivulva phenotype when inactivated simultaneously with a class A or C synMuv gene.

Results

We used the ORFeome RNAi library to identify genes that interact with C. elegans lin-35 Rb and identified 57 genes that showed synthetic or enhanced RNAi phenotypes in lin-35 mutants as compared to rrf-3 and eri-1 RNAi hypersensitive mutants. Based on characterizations of a deletion allele, the synthetic lin-35 interactor zfp-2 was found to suppress RNAi and to cooperate with lin-35 Rb in somatic gonad development. Interestingly, ten splicing-related genes were found to function similar to lin-35 Rb, as synMuv B genes that prevent inappropriate vulval induction. Partial inactivation of specific spliceosome components revealed further similarities with lin-35 Rb functions in cell-cycle control, transgene expression and restricted expression of germline granules.

Conclusion

We identified an extensive series of candidate lin-35 Rb interacting genes and validated zfp-2 as a novel lin-35 synthetic lethal gene. In addition, we observed a novel role for a subset of splicing components in lin-35 Rb-controlled processes. Our data support novel hypotheses about possibilities for anti-cancer therapies and multilevel regulation of gene expression.


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.